Literature DB >> 22176523

Whole blood rotation thromboelastometry (ROTEM(®)) in nine severe factor V deficient patients and evaluation of the role of intraplatelets factor V.

L Spiezia1, C Radu, E Campello, C Bulato, D Bertini, G Barillari, V De Angelis, P Pradella, E Zanon, P Simioni.   

Abstract

Severe factor V (FV) deficiency (parahaemophilia) is a rare congenital hemorrhagic disorder characterized by very low or undetectable plasma FV levels and bleeding phenotype ranging from mild to severe. We evaluated whole blood (WB) rotation thromboelastometry (ROTEM) in parahaemophilia patients and the contribution of intraplatelets FV, if any, to clot formation. Standard ROTEM(®) assays were performed in WB from nine parahaemophilia patients and 50 healthy controls. In addition, platelets poor plasma from one parahaemophilia patient (PPP-Pt) or normal subjects (PPP-N) was reconstituted with washed platelets obtained either from one patient with parahaemophilia (Plts-Pt) or normal subjects (Plts-N) and ROTEM assays were performed in platelets rich plasma (PRP) samples. There was a prolongation of the WB clotting time (CT) in all assays in patients as compared with controls. However, maximum clot firmness (MCF) was similar in patients and controls. ROTEM in PPP-Pt showed both a prolongation of CT and a reduction of MCF as compared with PPP-N. The addition of either Plts-Pt or Plts-N to PPP-Pt resulted in similar increase in MCF and a decrease of CT which was more evident for PPP-Pt + Plts-N than PPP-Pt + Plts-Pt. In contrast, the addition of Plts-Pt or Plts-N to PPP-N had superimposable effects on both CT and MCF. In parahaemophilia patients, WB ROTEM(®) presents mainly with prolongation of CT and no relevant effect on MCF. Residual intraplatelets FV in parahaemophilia contributes significantly to thrombin generation as shown in artificially reconstituted PRP models.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22176523     DOI: 10.1111/j.1365-2516.2011.02710.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  5 in total

1.  Exogenous human α-Synuclein acts in vitro as a mild platelet antiaggregant inhibiting α-thrombin-induced platelet activation.

Authors:  Laura Acquasaliente; Giulia Pontarollo; Claudia Maria Radu; Daniele Peterle; Ilaria Artusi; Anna Pagotto; Federico Uliana; Alessandro Negro; Paolo Simioni; Vincenzo De Filippis
Journal:  Sci Rep       Date:  2022-06-14       Impact factor: 4.996

2.  The use of frozen plasma samples in thromboelastometry.

Authors:  Christian Schoergenhofer; Nina Buchtele; Michael Schwameis; Johann Bartko; Bernd Jilma; Petra Jilma-Stohlawetz
Journal:  Clin Exp Med       Date:  2017-02-16       Impact factor: 3.984

3.  Phenotype Report on Patients with Congenital Factor V Deficiency in Southern Iran: Recent Ten Years' Experience.

Authors:  Mohammad Mostafa Safarpour; Sezaneh Haghpanah; Aidin Meshksar; Mehran Karimi
Journal:  Turk J Haematol       Date:  2017-03-08       Impact factor: 1.831

4.  Standardization of Coagulation Factor V Reference Intervals, Prothrombin Time, and Activated Partial Thromboplastin Time in Mice for Use in Factor V Deficiency Pathological Models.

Authors:  Juan A De Pablo-Moreno; Antonio Liras; Luis Revuelta
Journal:  Front Vet Sci       Date:  2022-03-28

5.  Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study.

Authors:  Elena Campello; Cristiana Bulato; Chiara Simion; Luca Spiezia; Claudia Maria Radu; Sabrina Gavasso; Francesca Sartorello; Graziella Saggiorato; Patrizia Zerbinati; Mariangela Fadin; Daniela Tormene; Paolo Simioni
Journal:  Thromb Haemost       Date:  2022-03-04       Impact factor: 6.681

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.